[Canagliflozin can improve cardiac function in HFpEF rats partly by regulating ferroptosis].
Canagliflozin 可以通過調節鐵死亡部分改善 HFpEF 大鼠的心臟功能。
Zhonghua Xin Xue Guan Bing Za Zhi 2024-09-18
Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy.
Canagliflozin 減輕了鐵死亡並改善糖尿病心臟病小鼠的心肌氧化壓力。
Front Endocrinol (Lausanne) 2022-11-02
Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway.
Canagliflozin 透過激活 AMPK 途徑,抑制炎症和鐵死亡,在心肌細胞中減輕脂毒性。
Int J Mol Sci 2023-02-07
Therapeutic effects on the development of heart failure with preserved ejection fraction by the sodium-glucose cotransporter 2 inhibitor dapagliflozin in type 2 diabetes.
藉由鈉葡萄糖共同轉運蛋白2抑制劑達帕格列酮在2型糖尿病患者中對保留射血分數心衰發展的治療效應。
Diabetol Metab Syndr 2023-07-03
Evaluating the potential impact of sodium-glucose cotransporter-2 inhibitor "canagliflozin" on the hepatic damage triggered by hypertension in rats.
評估鈉-葡萄糖共轉運蛋白-2 抑制劑 "canagliflozin" 對高血壓引發的肝損傷的潛在影響。
Microsc Res Tech 2024-07-25